Session II Abstracts

Click on abstract for more information

Session	Title	Author
M1	EVALUATION OF THE TRUtm RSV TEST FOR RAPID DETECTION OF RESPIRATORY SYNCYTIAL VIRUS IN PEDIATRIC PATIENTS	Kathy Mack, Douglas Salamon, and Mario Marcon Department of Laboratory Medicine, Nationwide Children?s Hospital, Columbus, OH
M2	DEVELOPMENT OF A MULTIPLEX MNAZYME ASSAY FOR RSV VIRAL QUANTIFICATION, MONITORED BY AN INTERNAL EXTRACTION CONTROL AND AN EXTERNAL QUANTIFICATION CONTROL	D Nauwelaers1, B Van Kerckhove1, T Ivens4, L Vijgen2, E Keyaerts2, M Van Ranst2, E Mokany3, A Todd3, T Gevers5, R Verloes4, D Roymans5 and L J Stuyver1 1Virco BVBA, Generaal De Wittelaan L 11B 4, B-2800 Mechelen, Belgium, 2Laboratory of Clinical Virology,
M3	COMPARISON OF A RAPID ANTIGEN TEST AND REAL-TIME POLYMERASE CHAIN REACTION FOR DETECTION OF RESPIRATORY SYNCYTIAL VIRUS FROM CHILDREN HOSPITALIZED WITH LOWER RESPIRATORY TRACK INFECTIONS	Karen Miernyk1, Carolynn DeByle2, Debra Parks2, Lisa Bulkow2, Jon Baker3, Lori Pruitt3, Helen Peters1, and Rosalyn Singleton1 1Alaska Native Tribal Health Consortium, Anchorage, AK, 2Arctic Investigations Program/DEISS/NCPDCID/CCID/CDC, Anchorage, AK, and
M4	COMPARISON OF THE AMOUNT OF RESPIRATORY SYNCYTIAL VIRUS COLLECTED USING NASOPHARYNGEAL WASH AND NASOPHARYNGEAL FLOCKED SWAB TECHNIQUES FROM CHILDREN HOSPITALIZED WITH LOWER RESPIRATORY TRACT INFECTIONS	Carolynn DeByle1, Karen Miernyk2, Debra Parks1, Lisa Bulkow1, Lori Pruitt3, Helen Peters2, and Rosalyn Singleton2 1Arctic Investigations Program/DEISS/NCPDCID/CCID/CDC, Anchorage, AK; 2Alaska Native Tribal Health Consortium, Anchorage, AK, and 3Yukon Kusk
M5	COMPARISON OF DIAGNOSTIC HYBRIDS D3 DUET (RSV AND INFLUENZA), D3 DOUBLE DUET AND D3 ULTRA DFA SCREENING REAGENTS FOR THE DETECTION OF 8 RESPIRATORY VIRUSES IN DIRECT SPECIMENS	M L. Ackerman Hamilton Regional Laboratory Medicine Program, St Josephs Healthcare, Hamilton ON, CANADA
M6	EVALUATION OF PROFLU+ FOR REAL-TIME AMPLIFICATION AND DETECTION OF INFLUENZA AND RESPIRATORY SYNCYTIAL VIRUSES	Butt, S.A., Clancy, T., Nattanmai, S., and Stellrecht, K.A. Department of Pathology and Laboratory Medicine, Albany Medical Center, Albany, NY 12208
M7	COMPARISON OF NASOPHARYNGEAL (NP) SWABS COLLECTED WITH PERNASAL FLOCKED SWABS VERSUS TO NP SWABS COLLECTED WITH TRADITIONAL TWISTED WIRE FIBER MINITIP FOR THE DETECTION OF RESPIRATORY VIRUSES USING SIMULFLUOR DFA	P. Ng1, J. Ng1, and T. Mazzulli1,2 1Department of Microbiology, Mount Sinai Hospital and 2University of Toronto, Toronto, Canada
M8	CLINICAL PERFORMANCE OF FOAM VS. FLOCKED SWABS COLLECTED FROM THE ANTERIOR NARES IN A RAPID ANTIGEN TEST FOR INFLUENZ A & B	Leber, and Mario Marcon Departments of Emergency and Laboratory Medicine, Nationwide Children's Hospital, Columbus, OH
M9	A MICROARRAY-BASED APPROACH TO INFLUENZA A DIAGNOSIS AND SURVEILLANCE	Dominic Suciu, Ph.D. and Michael Lodes, Ph.D. Combimatrix Corporation, Mukilteo, Washington
M10	GREATER THAN 10% OF INFLUENZA A (H1N1) ISOLATES AT CENTRAL PUBLIC HEALTH LABORATORY (CPHL), TORONTO, ONTARIO, CANADA ARE POSITIVE FOR THE NEURAMINIDASE H274Y MUTATION	Eshaghi, A.1, Burton, L1., Low, D.E.1,2,3,, Mazzulli, T.1,2,3, and Drews, S.J. 1,2,3 1Central Public Health Laboratory, Toronto, ON, Canada, 2Mount Sinai Hospital, Toronto, ON, Canada, and 3Department of Pathobiology and Laboratory Medicine, University
M11	EVALUATION OF SIMPLEXATM FLU-RSV ASSAY PERFORMANCE WITH ROCHE MAGNA PURE LC, BIOMERIEUX NUCLISENS® EASYMAGTM, AND QIAGEN QIAAMP® VIRAL RNA EXTRACTIONS	Jules Chen, Yuan Xie, Amanda O'Donahue, Chris Gardner, Susan Vogeli, Louis Geller, Ming-Chou Lee and Lilly Kong Focus Diagnostics, Inc., Cypress, CA 90630
M12	UTILITY OF MULTIPLEX REVERSE TRANSCRIPTION/REAL TIME PCR FOR DETECTION OF RSV, INFLUENZA A, AND INFLUENZA B IN NASOPHARYNGEAL ASPIRATES	L. Gluck, J.A. Wehrlin, C. Tilley, M. Forman, and A. Valsamakis Division of Medical Microbiology, Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, MD
M13	ERAGEN INFLUENZA REAL-TIME PCR ASSAY EVALUATION ON THE LIGHT CYCLER BY COMPARISON WITH EIA AND PMK SHELL VIAL	M Moghadamfalahi*, K McRae, J Vanchiere and J Matthews-Greer Louisiana State University Health Sciences Center at Shreveport jgreer@lsuhsc.edu
M14	EVALUATION OF THE NucliSENS EasyQ® INFLUENZA A/B ASSAY FOR THE DETECTION OF INFLUENZA A AND B VIRUSES	P. van Aarle1, N. Beaufet2, M. Touchard2, R. Cottarel2, and K. Brengel-Pesce2 1bioMérieux, Boxtel, The Netherlands and 2bioMérieux, R&D, Grenoble, France
M15	ADVANCES IN THE AUTOMATED DETECTION AND SUBTYPING OF INFLUENZA VIRUSES THAT INFECT HUMANS	J. He1, S. Kumar1, Y. Huang2, J. Fan1, M. Bose1, A.J Kraft1, W. G Weisburg2, E. L Mather2, and K. J.Henrickson1 1Department of Pediatrics, Medical College of Wisconsin, Milwaukee, Wisconsin; and 2Nanogen, Inc., San Diego, California
M16	PRE-CLINICAL EXPERIENCE WITH THE FluIDTM RAPID INFLUENZA TEST	Stan Vukajlovich1, Ph.D., Randy Madsen1, Ph.D., Sheetal Patel1, Mirela Dobre1, Wenli Huang1, Dan Weaver1, Li-Wen Huang1, Nick Hellmann2, M.D., Wendy Benson2, Yi Guan, Ph.D3., Honglin Chen3, Ph.D., and Richard Egan, Ph.D1 1Nanogen, Inc., San Diego, CA, 2HX
M17	RAPID DETECTION OF INFLUENZA VIRUSES: PERFORMANCE CHARACTERISTICS OF DIRECTIGEN EZ FLU A + B AND BINAXNOW® INFLUENZA A & B TESTS	S. H. Clemens, R. C. Alcabasa, D. Z. Aird, J. A. Wehrlin, and A. Valsamakis Division of Medical Microbiology, Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, MD
M18	CLINICAL EVALUATION OF THE 3M RAPID DETECTION FLU A+B TEST	C. C. Ginocchio, M. Lotlikar, L. Falk, M. Kowerska, S. Aurora and M. Bornfreund North Shore University Hospital, Manhasset, NY
M19	IMPROVED SENSITIVITY FOR CULTURING AND IDENTIFYING INFULENZA A SUBTYPES USING MDCK CELLS WITH ENHANCED EXPRESSION OF ALPHA 2, 6 LINKED SIALIC ACID MIXED WITH A-549 CELLS	Teresa Lee, Elaine Yeh, Gordon Shell, Maria Vu, Tasha Padilla, Estela Saguar, Janice Louie, and David Schnurr Viral and Rickettsial Disease Laboratory, California Department of Public Health, 850 Marina Bay Parkway, Richmond, CA 94804
M20	GENETICALLY ENGINEERED CELL LINES EXPRESSING INFLUENZA VIRUS-INDUCIBLE REPORTER GENES AS TOOLS FOR DETECTING AND QUANTIFYING INFLUENZA A OR B VIRUS	Yunsheng Li1, Andrew Pekosz3, Teresa Curtiss1, Audrey Larrimer1, Abby Jones1, Jaekyung Kim1, Paul Olivo2, Miguel E. Quinones-Mateu1 and Dave Scholl1 1Diagnostic HYBRIDS, Athens, OH, 2Apath, LLC, St, Louis, MO, and 3Johns Hopkins Bloomberg School of Publ
M21	SURVEILLANCE OF ANTIVIRAL RESISTANT INFLUENZA FROM 2006-2008 BY A NETWORK OF U.S. STATE PUBLIC HEALTH LABORATORIES	Laplante J1, Marshall SA2, Van T2, Reisdorf ES2, Shudt M1, Warshauer DM2, Shult PA2, and St. George K1 1Wadsworth Center, New York State Department of Health, Albany, NY, and 2Wisconsin State Laboratory of Hygiene, Madison, WI
M22	IDENTIFICATION OF MUTATIONS IN THE INFLUENZA A GENOME ASSOCIATED WITH ADAMANTANE AND NEURAMINIDASE INHIBITOR RESISTANCE DIRECTLY FROM CLINICAL SPECIMENS	E.S. Reisdorf, S.A. Marshall, T.T. Van, T.J. Whyte, P.A. Shult, and D.M. Warshauer Wisconsin State Laboratory of Hygiene, University of Wisconsin-Madison, Madison, WI
M23	DETECTION OF RNA AND NUCLEOPROTEIN ANTIGEN OF INFLUENZA A VIRUS IN STOOL OF CHILDREN	Anne Krivine1 MD, Jean-François Meritet1 PhD, Florence Moulin2 MD, Dominique Gendrel2,3 MD, Pierre Lebon1,3 MD 1 Laboratoire de Virologie, 2 Urgences pédiatriques, Hôpital Cochin Saint Vincent-de-Paul, 3 Université Paris Descartes, Paris, France
M24	DIRECT DETECTION OF INFLUENZA VIRUS TYPES A AND B IN CLINICAL SPECIMENS DURING THE 2007/2008 RESPIRATORY SEASON: ANTIGEN vs. PCR	M.J. Bankowski1,2, A. Chan1, T. Koyamatsu1 and W. Kim1 1Diagnostic Laboratory Services, Honolulu, HI, and 2John A. Burns School of Medicine, University of Hawaii, Honolulu, HI
M25	DIRECT DETECTION OF HUMAN METAPNEUMOVIRUS (hMPV) RNA IN RESPIRATORY SPECIMENS FROM PATIENTS PRESENTING WITH INFLUENZA-LIKE ILLNESS IN HAWAII	M.J. Bankowski1,2, A.C. Whelen3, A. Chan1, R.T. Ueki3, T. Koyamatsu1 and W. Kim1 1Diagnostic Laboratory Services, Honolulu, HI and 2John A. Burns School of Medicine, University of Hawaii, Honolulu, HI, and 3Hawaii Department of Health State Laboratories D
M26	COMPARISON OF R-MIX TOOTM FRESH CELLS WITH CONVENTIONAL CELLS LINES FOR THE RAPID TURN-AROUND-TIME IN THE DETECTION OF RESPIRATORY PATHOGENS USING THE DIAGNOSTIC HYBRID'S D³ ULTRATM RESPIRATORY SCREENING AND IDENTIFICATION REAGENTS	Cherry-Ann Da Costa, Carol Hamilton, Sara T. Beatrice, William R. Oleszko, and Maria Paz Carlos New York City Department of Health and Mental Hygiene Public Health Laboratory, New York, New York
M27	COMPARISON OF COPAN FLOCKED SWABS TO ROUTINE DACRON SWABS FOR THE COLLECTION OF NASOPHARYNGEAL SWABS FOR THE DIAGNOSIS OF RESPIRATORY VIRUSES	M Ferrés, P Valenzuela, T Hirsh, T Azocar, A Contreras, A Veloz, P Bustos, L Montecinos, T Espinoza, C Sandoval, and C Perret Virology Laboratory and Department of Pediatrics, School of Medicine, Pontificia Universidad Católica de Chile
M28	COMPARISON OF A MID-TURBINATE FLOCKED SWAB TO A NASOPHARYNGEAL FLOCKED SWAB FOR RESPIRATORY VIRUS DETECTION IN CHILDREN	Vanessa G. Allen, Rose Cheung, Karan Greenock, Carol Collins, John Nishikawa, Huyen Nguyen, Susan E. Richardson The Hospital for Sick Children and the University of Toronto, Toronto, Canada
M29	RESPIRATORY VIRAL RECOVERY FROM PEDIATRIC ASOPHARYNEGEAL SPECIMENS USING FLOCKED SWABS	Colleen Starkey, Louie Quimson, Donna Londrico, Lara Danzinger-Isakov, Debra Kohn, Sherrilyn Vogel, Bill Sholtis, Kim Kishmarton, Ann Roberto, Diane Warner, and B. Yen-Lieberman Cleveland Clinic, Cleveland, Ohio
M30	EVALUATION OF THE COPAN MID-TURBINATE FLOCKED SWAB FOR THE COLLECTION OF RESPIRATORY SPECIMENS FOR CELL CULTURE	Christine Biggs1, Lisa Slade2, Erica North2, and Steve Ewers2 1The Chester County Hospital, Pennsylvania1 and 2Diagnostic Hybrids, Ohio
M31	A COMPARISON OF NASOPHARYNGEAL AND MIDTURBINATE REGION SAMPLING FOR THE DETECTION OF RESPIRATORY PATHOGENS	Christine Biggs1, Christina Lim Overmyer2, Lisa DeSalvia2, Diana Gonzalez2, Larisa Gofman2, Melanie Feola2, Kathryn T. Iacono2, Eli Mordechai2 and Martin E. Adelson2 1The Chester County Hospital, West Chester, PA 19380; and 2Department of Research and De
M32	FLOCKED SWABS CAN BE USED WITH DRY SPECIMEN TRANSPORT IN NUCLEIC ACID AMPLIFICATION ASSAYS FOR THE SURVEILLANCE OF PANDEMIC INFLUENZA	Santina Castriciano Copan Italia, Brescia, Italy
M33	SELF-COLLECTED NASAL SWABS FOR DIAGNOSIS OF RESPIRATORY VIRUSES	S. Castriciano, S. Carruthers, M. Ackerman, S. Chong , C. Robinson, S. Buracond, G. So, J. Mahony and M Smieja Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada
M34	RECOVERY OF RESPIRATORY VIRUSES: SAMPLES COLLECTED BY FLOCKED SWABS COMPARED TO NASAL ASPIRATES	Tina Mueller, Janet O?Brien, Cheryl Drake, and Joan Barenfanger Memorial Medical Center, Springfield, IL
M35	PERFORMANCE OF RAPID EIA, DFA, RMIX, AND CONVENTIONAL CULTURE FOR DETECTION OF RESPIRATORY VIRUSES IN PEDIATRIC VS ADULT POPULATIONS	Fiebelkorn KR1, Walker J2, Hudson K2, Overton S2, Frazee-Gilson2 S, Gold O2, and Bartosh C2, and Lawless, K2 1University of TX Health Science Center at San Antonio and 2University Hospital, San Antonio, TX
M36	DETECTION OF RESPIRATORY VIRUSES IN NASOPHARYNGEAL ASPIRATES: COMPARISON OF DIRECT FLUORESCENT ANTIBODY TESTING AND XTAG RESPIRATORY VIRAL PANEL	S. Jemielity, M.T.Barbani, T.Staub, S. Leib and M. Gorgievski-Hrisoho Virology Department, Institute of Infectious Diseases, University of Berne, Switzerland
M37	ENHANCED DETECTION OF RESPIRATORY VIRUSES IN SYMPTOMATIC ADULTS USING THE LUMINEX xTAGTM RVP ASSAY	R. Manji1, F. Zhang1, M. Lotlikar2, L. Falk2, M. Kowerska2, L. Falk2, S. Arora2, and C. C. Ginocchio1, 2 1North Shore-LIJ Health System Laboratories, Lake Success, NY and 2North Shore University Hospital, Manhasset, NY
M38	ENHANCED ETIOLOGICAL DIAGNOSIS OF RESPIRATORY VIRUS OUTBREAKS USING NUCLEIC ACID AMPLIFICATION TESTING AGAINST AN EXPANDED RANGE OF TARGETS	Sallene Wong1, Bonita E. Lee2,3, Kanti Pabbaraju1, Kara L. Tokaryk1, Anita Wong1, Kevin Ho1 and Julie D Fox1,4 1Provincial Laboratory for Public Health (ProvLab), Calgary, 2ProvLab, Edmonton, 3Department of Pediatrics, University of Alberta, Edmonton, and
M39	COMPARISON OF REAL-TIME NUCLEIC ACID AMPLIFICATION TESTING FOR RESPIRATORY VIRUSES WITH THE LUMINEX RVP ASSAY	Vinod Khurana1, Kanti Pabbaraju1, Kara L. Tokaryk1, Sallene Wong1, Anita Wong1, Kevin Ho1 and Julie D Fox1,2 1Provincial Laboratory for Public Health (ProvLab), Calgary, Alberta and 2Microbiology & Infectious Diseases, University of Calgary, Calgary, Albe
M40	EVALUATION OF THE QIAGEN RESPLEX II ASSAY AND CORRELATION WITH THE CEPHEID SMART CYCLER ASR (INFLUENZA A AND B, RSV, AND ENTEROVIRUS) AND EIA ASSAYS	Arundhati Rao, MD, PhD, Linden Watson, Patricia Smith MT(ASCP), Asia Dudley, Daniel Smith, DO, Phd, Robert Fader, Phd, and Kimberly Hocker MT(ASCP) Scott and White Memorial Hospital, Temple, TX and Texas A&M University Health Science Center
M41	AUTOMATED EXTRACTION PLATFORMS AS FRONT END FOR RESPLEX II, SIMULTANEOUS DETECTION AND IDENTIFICATION OF A PANEL OF RESPIRATORY RNA VIRUSES IN RESPIRATORY SAMPLES	Marion Schmidt¬1§, Christian Kupfer1§, Thomas Hanselle¬1, Claudia van de Sand2, Ortwin Adams3, Linda Bonzel¬3, and Markus Sprenger-Haussels1 1QIAGEN GmbH, R&D Department, Hilden, Germany; §contributed equally, 2QIAGEN Hamburg GmbH, R&D Department, Hamburg
M42	PRACTICAL OBSERVATIONS FROM THE IMPLEMENTATION OF HIGHLY MULTIPLEX MOLECULAR TESTING AS A ROUTINE PART OF RESPIRATORY DIAGNOSIS	John Brunstein1,2 and Eva Thomas1 1Children?s and Women?s Health Centre of British Columbia, PHSA Labs, Vancouver BC and 2Centre for Translational and Applied Genomics, PHSA Labs, Vancouver BC
M43	THE SEEPLEX RV DETECTION KIT IDENTIFIES PATHOGENS IN THE MAJORITY OF RESPIRATORY OUTBREAKS FROM THE GREATER TORONTO AREA, ONTARIO, CANADA	J.E. Blair1, L. Burton1, E. Lombos1, C. De Lima1, T. Mazzulli1,2,3, and S.J.Drews1,2,3 1Central Public Health Laboratory, Toronto, ON, Canada, 2Mount Sinai Hospital, Toronto, ON, Canada, and 3Department of Pathobiology and Laboratory Medicine, University
M45	HIGH THROUGHPUT MOLECULAR DIAGNOSTICS FOR RESPIRATORY VIRUSES	Annika Tiveljung-Lindell, Maria Rotzén-Östlund, Shawon Gupta, Richard Ullstrand, Lena Grillner, Benita Zweygberg-Wirgart, and Tobias Allander Karolinska University Hospital, Stockholm, Sweden
M46	ANALYSIS OF 250 PEDIATRIC NPA SAMPLES FOR 22 RESPIRATORY PATHOGENS USING AN AUTOMATED, NESTED MULTIPLEX PCR PLATFORM	Mark Poritz1, Lindsay Meyers1, Amber Lewis1, Kody Nilsson1, Paul Murphy1, Meghan Hamilton1, Stephanie Thatcher1, Jamey Hulsberg1, Ron Mudrow1, Ben Smith1, Joanne Fisher1, David Jones1, Cory Estes1, David Teng1, Rich Abbott1, Steven Dobrowolski1, Anne Blas
M47	DETECTION RATES OF HUMAN CORONAVIRUS TYPES OC43, 229E, HKU1 AND NL63 IN CHILDREN HOSPITALIZED WITH ACUTE RESPIRATORY INFECTIONS AND WELL CHILDREN	Melisa Willby, PhD1, Aaron Curns, MPH1, Ryan Dare, MPH1, Dana Longo, MPH1, Geoffrey Weinberg, MD2, Kathryn Edwards, MD3, Mary Staat, MD, MPH4, John Williams, PhD3, Caroline Hall, MD2, Marika Iwane, PhD, MPH1, Peter Szilagyi, MD, MPH2, and Dean Erdman, Dr
M48	DETECTION OF RESPIRATORY VIRUS OUTBREAKS IN CHILDREN: A COMPARISON OF MOLECULAR LABORATORY-BASED SURVEILLANCE VERSUS TELEPHONE-BASED SYNDROMIC SURVEILLANCE	B. Ammons1, J. Mahony2, S. Chong2, E. Moore3, K. Moore3, A. van Dijk3 and M. Smieja1,2 1Department of Health Sciences, Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario; 2Department of Pathology and Molecular Medicine, McMast
M49	ETIOLOGY OF RESPIRATORY VIRAL INFECTIONS USING RAPID VIRUS ISOLATION METHODS: EXPERIENCE AT A TERTIARY CARE CENTER IN RIYADH, SAUDI ARABIA	Akhter J, Al Johani S, Dugaishm F, Al Hefdi R, and Muhanna A. Pathology and Laboratory Medicine, King Abdulaziz Medical City, Riyadh 11426, Saudi Arabia
M50	COMPARISON OF METHODS IN THE DETECTION OF RESPIRATORY VIRUSES	E. K. Korgenski1,2, A. T. Barney1, R. Brogdon1, E. Noordewier1, M. Dickey1, and J. A. Daly1,2 Primary Children?s Medical Center1 and University of Utah2 Salt Lake City, UT
M51	AUTOMATED MOLECULAR DIAGNOSTIC OF RESPIRATORY VIRUSES IN CHILDREN	Frédéric Raymond1, Julie Carbonneau1, Lynda Robitaille1, Nancy Boucher1, Whei-Kuo Wu2, Gaston De Serres3, Guy Boivin1,4 and Jacques Corbeil1,5 1Infectiology Research Centre, Université Laval, Canada, 2AutoGenomics, Inc., Carlsbad, CA, 3Institut national d
M52	SINGLE RESPIRATORY COLLECTION SYSTEM, STARPLEX S-160 NASO, FOR MULTIPLE INVESTIGATIONS	R.Wheeler, D. Hathaway, T. Hayes, D. Jaskot, J. Krahn, S. Milburn, A. Tirolese, and R. Lannigan Virology Department, London Laboratory Services Group, London, Ontario
M53	EVALUATION OF R-MIX TOO VIALS FOR CULTURE OF RESPIRATORY VIRUSES	K. Loveall1 and A. Robinson1,2 Virology Laboratory, Pathology Associates Medical Laboratories1 and Microbiology Laboratory, Sacred Heart Medical Center2, Spokane, WA
M54	COMPARISON OF EIA, DFA, AND CULTURE FOR DETECTION OF HUMAN METAPNEUMOVIRUS	K. Loveall1 and A. Robinson1,2 1Virology Laboratory, Pathology Associates Medical Laboratory and 2Microbiology Laboratory, Sacred Heart Medical Center, Spokane, WA
M55	COMPARISON OF PREVALENCE AND CLINICAL FEATURES OF PEDIATRIC RESPIRATORY INFECTIONS DUE TO RESPIRATORY SYNCYTIAL VIRUS AND HUMAN METAPNEUMOVIRUS	C. Beneri1, R. Manji2, S. Sood 1, and C. C. Ginocchio 1,2 1North Shore University Hospital, Manhasset, NY, and 2North Shore-LIJ Health System Laboratories, Lake Success, NY
M56	EVALUATION OF THE PRODESSE PRO HMPV+ ASSAY -A REAL TIME RT-PCR TEST FOR DETECTION OF HUMAN METAPNEUMOVIRUS FROM CLINICAL TRIALS IN A PEDIATRIC PATIENT POPULATION	Damon Lacey1, C. Macklyn Langley1, Beverly B. Rogers MD 1,2, and Paula A. Revell, PhD1,2. 1Children's Medical Center, Dallas, TX and 2University of Texas Southwestern Medical Center, Dallas, TX
M57	DETECTION OF HUMAN METAPNEUMOVIRUS IN NASOPHARYNGEAL ASPIRATES: PREVALENCE AND EFFICACY OF DETECTION BY DIRECT FLUORESCENT ANTIBODY	K. Fackrell, M.S. Forman, J.A. Wehrlin and A. Valsamakis Division of Medical Microbiology, Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, MD
M58	OBSERVATIONS ON METAPNEUMOVIRUS TESTING	Scott Hite 1 and Yung T. Huang 1,2 1University Hospitals Case Medical Center, Cleveland OH and 2Case Western Reserve University, Cleveland OH.
M59	EVALUATION OF A REAL-TIME ASSAY FOR HUMAN METAPNEUMOVIRUS DETECTIONBackground: Human metapneumovirus (hMPV), a newly described member of the Paramyxoviridae family, has been shown to be a cause of acute respiratory tract infections in young children, the	Weston C. Hymas1 and David R. Hillyard1,2 Associated Regional and University Pathologists Institute for Clinical and Experimental Pathology1and Department of Pathology2, University of Utah Health Sciences Center, Salt Lake City, Utah, 84108
M60	EVALUATION OF NUCLISENSE ANALYTE SPECIFIC REAGENTS (ASR) FOR THE DETECTION OF HUMAN METAPNEUMOVIRUS IN CLINICAL SPECIMENS	Duane Newton1, Clarise Starr1, Marisa Louie2, Nour Akhras3, Amy Lionquist1, and Rosemary Hankerd1 Departments of 1Pathology, 2Emergency Medicine, and 3Pediatrics and Communicable Diseases University of Michigan Hospitals and Health Centers, Ann Arbor, MI
M61	EVALUATION OF IMAGEN HMPV - A NEW DIRECT FLUORESCENT ANTIBODY TEST	Lianne Card, Sarah Couch and Barbara Fallowfield Thermo Fisher Scientific Ltd, Ely, UK
M62	A COMPARISON OF NEW IMAGEN hMPV IMMUNOFLUORESCENT ANTIBODY ASSAY VS PCR	Lianne Card, Sarah Couch and Barbara Fallowfield Thermo Fisher Scientific Ltd, Ely, UK
M63	COMPARISON OF TWO NEW DFA ASSAYS TO RT-PCR FOR THE DETECTION OF HUMAN METAPNEUMOVIRUS IN RESPIRATORY SPECIMENS	A. Petrich1, M. Booth1, K. Luinstra1, M. Ackerman1, S. Castriciano2, M. Smieja1, and J. Mahony1 1St. Josephs Healthcare, Hamilton, ON, Canada, and 2Copan Italia, Brescia, Italy